Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics
Frontiers in Cell and Developmental Biology · 25.05.2023 · 11
DOI: 10.3389/fcell.2023.1125174 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Frontiers in Cell and Developmental Biology, online erschienen am 25.05.2023. Verfasst von Mia C Borlongan und 1 weiteren Autor:innen. Beteiligte Einrichtung: Master Program of Pharmaceutical Science College of Graduate Studies, Elk Grove, CA, United States. Die Arbeit wurde bisher 53-mal zitiert (Crossref) und nennt 280 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0).
Abstract (Originalsprache)
Tumorigenic cancer stem cells (CSCs) represent a subpopulation of cells within the tumor that express genetic and phenotypic profiles and signaling pathways distinct from the other tumor cells. CSCs have eluded many conventional anti-oncogenic treatments, resulting in metastases and relapses of cancers. Effectively targeting CSCs’ unique self-renewal and differentiation properties would be a breakthrough in cancer therapy. A better characterization of the CSCs’ unique signaling mechanisms will improve our understanding of the pathology and treatment of cancer. In this paper, we will discuss CSC origin, followed by an in-depth review of CSC-associated signaling pathways. Particular emphasis is given on CSC signaling pathways’ ligand-receptor engagement, upstream and downstream mechanisms, and associated genes, and molecules. Signaling pathways associated with regulation of CSC development stand as potential targets of CSC therapy, which include Wnt, TGFβ (transforming growth factor-β)/SMAD, Notch, JAK-STAT (Janus kinase-signal transducers and activators of transcription), Hedgehog (Hh), and vascular endothelial growth factor (VEGF). Lastly, we will also discuss milestone discoveries in CSC-based therapies, including pre-clinical and clinical studies featuring novel CSC signaling pathway cancer therapeutics. This review aims at generating innovative views on CSCs toward a better understanding of cancer pathology and treatment.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Master Program of Pharmaceutical Science College of Graduate Studies, Elk Grove, CA, United States.
- Department of Pharmaceutical and Biomedical Sciences College of Pharmacy, Elk Grove, CA, United States.
- Department of Basic Science College of Medicine, California Northstate University, Elk Grove, CA, United States.
Zitieren
APA
Borlongan, M. C., & Wang, H. (2023). Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. Frontiers in Cell and Developmental Biology, 11. https://doi.org/10.3389/fcell.2023.1125174
Vancouver
Borlongan MC, Wang H. Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics. Frontiers in Cell and Developmental Biology. 2023;11. doi:10.3389/fcell.2023.1125174
BibTeX
@article{Borlongan2023,
author = {Borlongan, Mia C and Wang, Hongbin},
title = {Profiling and targeting cancer stem cell signaling pathways for cancer therapeutics},
journal = {Frontiers in Cell and Developmental Biology},
year = {2023},
volume = {11},
doi = {10.3389/fcell.2023.1125174}
}
EUVIMED